Clinical Research Fellow
- AMALFI (Active Monitoring for AtriaL FIbrilation)
- ORION-4 (A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease)
I am a NIHR Oxford Biomedical Research Centre Clinical Research Fellow, based at the Clinical Trial Service Unit (CTSU). Here, I am working under the joint supervision of Professor Barbara Casadei and Professor Louise Bowman in the AMALFI (Active Monitoring for AtriaL FIbrilation) trial, a study which aims to shed light on the burden of subclinical atrial fibrillation in elderly high-risk patients. I am also part of the clinical team for the ORION-4 (A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease) trial, a study which is assessing the effect of inclisiran, a novel cholesterol-lowering therapy, on cardiovascular events on patients with established atherosclerotic disease. My research interests include atrial fibrillation, heart failure and cardiovascular imaging, as well as randomised controlled trials and big data approaches to studying cardiovascular disease.
I studied medicine at the Faculty of Medicine of the University of Porto, in Portugal, having graduated in 2017. After that, I completed a one-year clinical internship at Gaia-Espinho Hospital Centre, a tertiary hospital in Northern Portugal. During this year I gained experience in internal medicine, clinical cardiology and primary care, having worked in inpatient wards, emergency room and outpatient clinic. This intense and rewarding year of clinical work, together with the exciting research experience as part of my medical degree, made me want to pursue a career as a clinician-scientist in cardiology, placing myself at the intersection between clinical practice and medical research.
Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology.
Pessoa-Amorim G. et al, (2020), Eur Heart J Qual Care Clin Outcomes, 6, 210 - 216
Impaired Left Atrial Strain as a Predictor of New-onset Atrial Fibrillation After Aortic Valve Replacement Independently of Left Atrial Size
Pessoa-Amorim G. et al, (2018), Revista Espanola de Cardiologia, 71, 466 - 476